LabCompass

Erik Parker

Medicine · Indiana University

Publications

50

Citations

1,456

Est. group size

Recurring co-author estimate

Active years

28

Publishing since 1998

Research summary
AI-generated

Erik Parker's research spans brain cancer biology and the study of microbial communities (the microbiome) in health and disease. Earlier work examined how a cell-surface receptor called GPR133 contributes to the growth of glioblastoma, an aggressive brain tumor, while more recent work explores how gut and other microbiomes relate to metabolism, cognition, and aging in animal models. The topics reflect a shift from tumor cell biology toward microbiome-focused studies.

Glioblastoma and brain tumor biologyG-protein-coupled receptors in cancerGut microbiome and healthMicrobiome, metabolism, and cognitionAging and neurodegeneration models

Publication activity was minimal for several years and then increased around 2023–2024, indicating recent growth in output.

Generated by claude-opus-4-8 from public bibliographic data · Jul 11, 2026

Publication cadence
Publications per year over the last 10 years — averaging 1.6/year recently
1718192021222023: 2 publications232024: 5 publications5242025: 1 publication2526
Recent publications
Publishes in
  • Oncogenesis×1
  • Frontiers in Allergy×1
  • Social Science Quarterly×1
  • Aging Brain×1
  • American Journal of Clinical Nutrition×1

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 11, 2026.

Claim or correct this profile